# Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:

> **NCT05877235** · NA · COMPLETED · sponsor: **InCor Heart Institute** · enrollment: 60 (actual)

## Conditions studied

- Coronary Artery Disease
- Menopause

## Interventions

- **DIETARY_SUPPLEMENT:** Quercetin
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05877235
- **Lead sponsor:** InCor Heart Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-03
- **Primary completion:** 2023-12-23
- **Final completion:** 2024-06-23
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05877235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05877235, "Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05877235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*